IRIX News and Press, IRIDEX Corporation From 05/13/25

MOUNTAIN VIEW, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial re...

urban-gro Inc. (UGRO) is expected to report for quarter end 2025-03-31 Karman Holdings Inc. (KRMN) is expected to report $0.02 for Q1 2025 PyroGenesis Inc Com (PYRGF) is expected to report for quarter end 2025-03-31 GeoVax Labs Inc. (GOVX) is expected to report $-0.59 for Q1 2025 ...

2025-05-01 18:00:20 ET Summary IRIDEX's strategic review ended without a major asset sale, but a $10M investment from Novel Inspiration International offers growth potential and cash stability. Novel's investment values IRIDEX shares at $2.00/share, significantly higher than curre...

MOUNTAIN VIEW, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Company pl...

2025-04-16 19:11:02 ET IRIDEX Corporation (IRIX) Strategic Vision Conference Call April 16, 2025 05:00 PM ET Company Participants Trip Taylor - Investor Relations Patrick Mercer - Chief Executive Officer Will Moore - Board of Directors Conference Call Parti...

2025-04-14 16:21:11 ET More on IRIDEX Iridex outlines 2025 growth strategy with $10M strategic investment and cost reduction focus Iridex shares rise on new CFO appointment, $10 million investment Financial information for IRIDEX Read the full article on Se...

MOUNTAIN VIEW, Calif., April 14, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced preliminary una...

MOUNTAIN VIEW, Calif., April 09, 2025 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced the Compa...

2025-03-27 18:04:28 ET More on IRIDEX IRIDEX Corporation (IRIX) Q4 2024 Earnings Call Transcript Iridex shares rise on new CFO appointment, $10 million investment Iridex reports preliminary Q4 and FY24 total revenue Financial information for IRIDEX ...

2025-03-27 18:03:51 ET IRIDEX Corporation (IRIX) Q4 2024 Earnings Conference Call March 27, 2025, 5:00 PM ET Company Participants Trip Taylor - Investor Relations Department Patrick Mercer - Chief Executive Officer Romeo Dizon - Chief Financial Officer Conf...